The resistivity increases gradually with decreasing temperature a

The resistivity increases gradually with decreasing temperature and varies slightly from 0.0093 Ω · cm (T = 300 K) to 0.011 Ω · cm (T = 5 K). Combined with the structure of sample A, the Ion Channel Ligand Library mw transport process is probably dominated by metallic paths because of the large number of interconnected elongated Co particles (see Figure 3a), which decreases when the resistivity increases, accompanying an increased MR effect. The approximate linear relationship between ρ and ln T for sample A is shown in Figure 5f. The fitting value of straight slope is shown in Table 1. The same phenomenon was reported in a CoO-coated monodispersive Co cluster system

corresponding to a small negative MR value in a metal/semiconductor transition regime [30] and in the CoFeB/MgO films, in which the sample with high magnetic metal concentration is not in the strongly localized regime of conduction and the resistivity Tipifarnib solubility dmso is plotted as a linear function of log(T) [31]. Further detailed studies are

necessary and in progress to elucidate the mechanism behind this result. Conclusions In summary, the structure, magnetic properties, and MR effect were investigated in Co/ZnO films deposited by sputtering at different pressures with different ZnO contents. We observed that the MR effect is strongly related to the resistivity buy LXH254 of the films. Based on conduction, the MR effect can be classified into three regimes: the metallic, tunneling, and hopping regimes. Large RT MR values greater than 8.1% were obtained in the tunneling regime with a range of resistivity from 0.08 to 0.5 Ω · cm. By

contrast, the MR value decreases distinctly when the resistivity of the films is less than 0.08 Ω · cm (metallic regime) or greater than 0.5 Ω · cm (hopping regime). In the tunneling regime, the conduction of the films mainly has two channels: the spin-dependent tunneling channel, which gives rise to high RT MR effect, and the spin-independent second-order hopping (N = 2). In the hopping regime, Selleckchem BIBF-1120 the increased spin-independent higher-order hopping (N > 2) through the localized states in thicker ZnO matrix served an important function and is the main reason for the rapid decrease in tunneling MR. In the metallic regime, metallic paths between interconnected elongated Co particles impede the MR effect. These results facilitate a deeper understanding of the spin transport mechanism in metal/semiconductor granular films and are significant for the improvement of the RT MR effect in spintronic applications. Acknowledgements The work is financially supported by NSFC (nos. 51025101 and 11274214), the Special Funds of Shanxi Scholars Program, the Ministry of Education of China (nos. IRT 1156 and 20121404130001), and the Youth Science Foundation of Shanxi Province (2012021020–2). References 1.

CrossRefPubMed 62 Chen L, Ashe S, Brady WA, Hellstrom I, Hellstr

CrossRefPubMed 62. Chen L, Ashe S, Brady WA, Hellstrom I, Hellstrom KE, Ledbetter JA, McGowan P, Linsley PS: Costimulation of anti-tumour immunity by the B7 counter receptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 1992, 71: 1093–1102.CrossRefPubMed 63. Townsend SE, Allison

JP: Tumour rejection after direct costimulation of CD8+ Pitavastatin in vitro T cells by B7-transfected melanoma cells. Science 1993, 259: 368–370.CrossRefPubMed 64. Eberlein T, Rosenstein M, Rosenberg S: Regression of a disseminated syngeneic solid tumour by systemic transfer of lymphoid cells expanded in interleukin 2. J Exp Med 1982, 156: 385–397.CrossRefPubMed 65. Rosenberg S, Spiess P, Lafreniere R: A new approach to the adoptive immunotherapy of cancer with tumourinfiltrating lymphocytes. Science selleckchem 1986, 233: 1318–1321.CrossRefPubMed 66. Overwijk W, Tsung A, Irvine K, Parkhurst

MR, Goletz TJ, Tsung K, Carroll MW, Liu C, Moss B, Rosenberg SA, Restifo NP: gp100/pmel 17 is a murine tumour rejection antigen: Induction of self reactive, tumouricidal T cells using high-affinity, altered peptide ligand. J Exp Med 1998, 188: 277–286.CrossRefPubMed 67. Rosenberg S, Terry W: Passive immunotherapy of cancer in animals and man. Adv Cancer Res 1977, 25: 323.CrossRefPubMed 68. Rosenberg SA, Yannelli JR, Yang JC, MRT67307 mouse Topalian SL, Schwartzentruber DJ, Weber JS, Parkinson DR, Seipp CA, Einhorn JH, White DE: Treatment of patients with metastatic melanoma with autologous tumour-infiltrating lymphocytes and interleukin 2. J Natl Cancer Inst 1994, 86: 1159–1166.CrossRefPubMed 69. Yee C, Thompson J, Roche P, Byrd DR, Lee PP, Piepkorn M, Kenyon K, Davis MM, Riddell SR, Greenberg PD: Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligo. J Exp Med 2000, 192: 1637–1644.CrossRefPubMed 70. Dudley M, Wunderlich J, Nishimura

M, Yu D, Yang JC, Topalian SL, Schwartzentruber DJ, Hwu P, Marincola FM, Sherry R, Leitman SF, Rosenberg SA: Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma. J Immunother 2001, Exoribonuclease 24: 363–373.CrossRefPubMed 71. Dudley M, Wunderlich J, Yang JC, Hwu P, Schwartzentruber DJ, Topalian SL, Sherry RM, Marincola FM, Leitman SF, Seipp CA, Rogers-Freezer L, Morton KE, Nahvi A, Mavroukakis SA, White DE, Rosenberg SA: A phase I study of nonmyeloablative chemotherapy and adoptive transfer of autologous antigen-specific T lymphocytes in patients with metastatic melanoma. J Immunother 2002, 25: 243–251.CrossRefPubMed 72. North R: Cyclophosphamide-facilitated adoptive immunotherapy of an established tumour depends on elimination of tumour-induced suppressor T cells. J Exp Med 1982, 155: 1063–1074.CrossRefPubMed 73.

Occup Environ Med 60:i32–i39 doi:10 ​1136/​oem ​60 ​suppl_​1 ​i3

Occup Environ Med 60:i32–i39. doi:10.​1136/​oem.​60.​suppl_​1.​i32 CrossRef Karasek R, Theorell T (1990) Healthy work: stress, productivity and the reconstruction of working life. Basic Books, New York Karasek R, Brisson C, Kawakami

N, Houtman I, Bongers P, Amick B (1998) The Job Content Questionnaire (JCQ): an instrument for internationally comparative assessments of psychosocial job characteristics. J Occup Health Psychol check details 3:322–355CrossRef Kiss P, De Meester M, Braeckman L (2008) Differences between younger and older workers in the need for recovery after work. Int Arch Occup Environ Health 81:311–320. doi:10.​1007/​s00420-007-0215-y CrossRef Lautenbach H (2006) Relatie meervoudige werkbelasting en burn-out bij vrouwen (Relationship between double burden and burn-out in women). Soc Econ Trends 2:11–14 Macintyre S, Hunt K, Sweeting H (1996) Gender differences in health: are things really as simple as they seem? Soc Sci Med 42:617–624. doi:10.​1016/​0277-9536(95)00335-5 CrossRef Meeuwesen see more L, Bensing J, Van den Brink-Muinen A (2002) Communicating fatigue in general practice and the role of gender. Patient Educ Couns 48:233–242CrossRef Meijman TF, Mulder G (1998) Psychosocial aspects of workload. In: Drenth PJD, Thierry H, Wolff CJ (eds) Handbook of work, organizational psychology. Psychology Press, Hove, pp 5–33 Meijman TF, Zijlstra FRH (2007) Arbeid en mentale inspanning. In: Schaufeli WB, Bakker A (eds) De psychologie van

arbeid en gezondheid (The psychology of work and health). Bohn Stafleu Van Loghum, Houten, pp 51–70 Nelson DL, Burke RJ (2002) Gender, out work and health. American Psychological Association, WashingtonCrossRef Otten F, Smulders P, Andries F (2002) Arbeidsuitval door burn-out (Sickness absence due to burn-out). Econ Stat Ber 4:11–13 Peretti-Watel P, Legleye S, Baumann M, Choquet M, Falissard B, Chau N, The Lorhandicap group (2009) Fatigue, insomnia and nervousness: gender disparities and roles of individual characteristics

and lifestyle factors among economically active people. Soc Psychiatry Psychiatr Epidemiol. On-line first. doi: 10.​1007/​s00127-008-0487-x Portegijs W, Cloïn M, Keuzenkamp S, Merens A, Steenvoorden E (2008) Verdeelde tijd. Waarom vrouwen in deeltijd werken (Divided time. Why women work part-time). Den Haag: Sociaal en Cultureel Planbureau. Download 11 November 2008 from http://​www.​scp.​nl/​publicaties/​boeken/​9789037703979/​Verdeelde%20​tijd.​pdf this website Pugliesi K (1999) Gender and work stress: differential exposure and vulnerability. J Gend Cult Health 4:97–117. doi:10.​1023/​A:​1023257726254 CrossRef Sluiter JK, De Croon EM, Meijman TF, Frings-Dresen MHW (2003) Need for recovery from work related fatigue and its role in the development and prediction of subjective health complaints. Occup Environ Med 60(Suppl 1):i62–i70. doi:10.​1136/​oem.​60.​suppl_​1.​i62 CrossRef Smulders P, Klein Hesselink J (1999) Agressie en geweld op het werk (Agression and violence at work).

Herein, we report a one-step self-driven process to synthesize mu

Herein, we report a one-step self-driven process to synthesize multifunctional Sotrastaurin price HSSs under an acidic condition with rare-earth ion assistance. Compared with Wang’s report, the synthetic approach of HSSs is simpler. Being synthesized with the assistance of rare-earth ions, the as-prepared HSSs can emit bright fluorescence under ultraviolet radiation, which is convenient to be detected in real time if it is used in biological applications. Typical drug loading and release experiments are carried out using our prepared multifunctional HSSs, SiO2 · Eu2O3 HSs. Methods All chemicals were of analytical grade and purchased from Jinan Camolai

Trading Company (Jinan, China), which were used as received without further purification: tetraethyl orthosilicate (TEOS, 98%), ammonium hydroxide this website solution (NH3 · H2O, approximately 25% in water), nitric acid (HNO3, 65%), Re2O3, and ethanol (C2H5OH). Rare-earth nitrate solutions [Re(NO3)3 (Re = Y, Eu, La, Sm, Tb, Pr)] with a concentration of 0.04 to 0.08 mol/L were prepared by ourselves. Synthesis of monodisperse silica spheres Silica spheres with a diameter of 200 to 500 nm were prepared by the hydrolysis of TEOS in the mixture of ethanol, buy R428 water, and ammonium using the Stöber process [37–39]. Synthesis of SiO2 · Re2O3 hollow spheres In a typical synthesis, silica spheres (0.06 g) were added to 20 mL Re(NO3)3 (0.06 mol/L) and stirred for 30 min. The pH of the solution

is 4.5 (adjusted with dilute nitric acid). The mixture was transferred into a Teflon-lined stainless autoclave (capacity 25 mL) and heated at 250°C for 12 h. After the products naturally cooled down to room temperature, they were washed with deionized water

and separated by centrifugation (4,000 rpm) for three times and then dried at 60°C for 4 h in the air. Drug storage and release The steps of drug storage and release are as follows: 1. SiO2 · Eu2O3 HSs (1 g) were added into a 50-mL hexane solution containing 40 mg/mL ibuprofen (IBU). The mixture Osimertinib datasheet was sealed and stirred for 24 h. Then the sample was separated by centrifugation and dried at 60°C in the air. The filter was characterized by UV-visible (UV–vis; 264 nm) spectroscopy.   2. The dry SiO2 · Eu2O3 loaded with IBU (0.1 g) was immersed into 50 mL of simulated body fluid (SBF; pH = 7.4) at 37°C and stirred at the rate of 100 rpm. Three milliliters from the top of the solution was used for release measurement at different intervals, and then 3 mL of fresh SBF is added into the solution to keep the volume unchanged.   Characterization and instruments The characterization and instruments used are detailed as follows: 1. The samples were characterized by X-ray diffraction (XRD) with a Philips X’Pert Super diffractometer (Amsterdam, The Netherlands) with graphite-monochromatized Cu Kα radiation (λ = 1.54178 Å) in the 2θ range of 1.5° to 10° and 10° to 80°.   2.

Optimization of CS and TPP concentrations To optimize the CS/TPP

Optimization of CS and TPP concentrations To optimize the CS/TPP ratio based on particle size and the entrapment efficiency, various CS concentrations (0.2%, 0.3%, and 0.4% (w/v)) were prepared from the stock solution. The concentrated TPP solution (0.5% (w/v)) was used in order not to dilute the CS/ASNase II mixture

more than necessary. From this stock solution, different volumes of TPP solution (Table 1) were added dropwise (10 μl per 10 s interval) to 1 ml of each CS concentration (containing 1 mg lyophilized ASNase II) with stirring (about 800 rpm), with particular care taken to avoid foam formation. In addition to the applied volumes of TPP, Table 1 shows the final concentrations of the added TPP (% w/v). All procedures were carried out at room selleck inhibitor temperature (25°C). After 10 min of stirring, the particles were collected by centrifugation at 25,000 × g, 25°C for 30 min in 50-μl glycerol bed. The supernatants selleck kinase inhibitor were separated to estimate the entrapment efficiency (%). The pellets of the particles in glycerol were suspended in 1 ml of distilled water to 4SC-202 mouse determine the average sizes (nm). Table 1 Chitosan concentrations,

TPP volumes from TPP stock solution (0.5%  w / v ), and final TPP concentrations in final prepared nanoparticle suspensions CS (% w/ v) TPP (ml) TPP (% w/ v) 0.2 0.1 0.04 0.12 0.05 0.14 0.06 0.3 0.15 0.06 0.18 0.07 0.21 0.08 0.4 0.2 0.08 0.24 0.095 0.28 0.11 Optimization of protein loading The stable and suitable CS/TPP ratio from the previous step was selected in order to investigate the optimal entrapment efficiency and loading capacity of CSNPs, loaded with five different Selleck Baf-A1 amounts of protein

(1, 2, 3, 4, and 5 mg). Nanoparticles were prepared according to the procedure given above by adding a certain amount of lyophilized ASNase II in 1 ml of optimal CS solution. After centrifugation, the supernatants were separated to estimate the entrapment efficiency. The pellets of the particles in glycerol were suspended in 1 ml of DDW and dispersed by sonication. The size (nm), zeta potential (mV), protein content (mg), entrapment efficiency (%), and loading capacity (%) of the particles were determined. Entrapment efficiency estimation In order to determine the entrapment efficiency of the nanoparticles, it was necessary to detect by the Lowry method [21] the amount of free enzyme in the clear supernatant.

Science 2001,293(5538):2266–2269 PubMedCrossRef 11 Sibbald MJJB,

Science 2001,293(5538):2266–2269.PubMedCrossRef 11. Sibbald MJJB, Winter T, van der Kooi-Pol MM, Buist G, Tsompanidou E, Bosma

T, Schafer T, Ohlsen K, Hecker M, Antelmann H, et al.: Synthetic effects of secG and secY2 mutations on exoproteome biogenesis in Staphylococcus aureus . J Bacteriol 2010,192(14):3788–3800.PubMedCrossRef 12. Siboo IR, Chaffin DO, Rubens CE, Sullam PM: Characterization of the accessory Sec system of Staphylococcus aureus . J Bacteriol 2008,190(18):6188–6196.PubMedCrossRef 13. Lee E-Y, Choi D-Y, Kim D-K, Kim J-W, Park JO, Kim S, Kim S-H, Desiderio DM, Kim Y-K, Kim K-P, et al.: Gram-positive bacteria produce membrane vesicles: Proteomics-based characterization of Staphylococcus aureus -derived membrane vesicles. Proteomics 2009,9(24):5425–5436.PubMedCrossRef 14. Solis N, Larsen MDV3100 cost MR, Cordwell SJ: Improved accuracy of cell surface ZD1839 cost shaving proteomics in Staphylococcus PR-171 aureus using a false-positive control. PROTEOMICS 2010,10(10):2037–2049.PubMedCrossRef

15. Hempel K, Pané-Farré J, Otto A, Sievers S, Hecker M, Becher D: Quantitative cell surface proteome profiling for SigB-dependent protein expression in the human pathogen Staphylococcus aureus via biotinylation approach. J Proteome Res 2010,9(3):1579–1590.PubMedCrossRef 16. Chaudhuri R, Allen A, Owen P, Shalom G, Stone K, Harrison M, Burgis T, Lockyer M, Garcia-Lara J, Foster S, et al.: Comprehensive identification of essential Staphylococcus P-type ATPase aureus genes using transposon-mediated differential hybridisation (TMDH). BMC Genomics 2009,10(1):291.PubMedCrossRef 17. Tseng TT, Gratwick KS, Kollman J, Park D,

Nies DH, Goffeau A, Saier MH Jr: The RND permease superfamily: An ancient, ubiquitous and diverse family that includes human disease and development proteins. J Mol Microbiol Biotechnol 1999,1(1):107–125.PubMed 18. Thanassi DG, Cheng LW, Nikaido H: Active efflux of bile salts by Escherichia coli . J Bacteriol 1997,179(8):2512–2518.PubMed 19. Davies JP, Chen FW, Ioannou YA: Transmembrane molecular pump activity of Niemann-Pick C1 protein. Science 2000,290(5500):2295–2298.PubMedCrossRef 20. Takatsuka Y, Chen C, Nikaido H: Mechanism of recognition of compounds of diverse structures by the multidrug efflux pump AcrB of Escherichia coli . Proc Natl Acad Sci USA 2010,107(15):6559–6565.PubMedCrossRef 21. Nikaido H: Multidrug efflux pumps of Gram-negative bacteria. J Bacteriol 1996,178(20):5853–5859.PubMed 22. Rohrer S, Ehlert K, Tschierske M, Labischinski H, Berger-Bächi B: The essential Staphylococcus aureus gene fmhB is involved in the first step of peptidoglycan pentaglycine interpeptide formation. PNAS 1999,96(16):9351–9356.PubMedCrossRef 23. Bae T, Schneewind O: Allelic replacement in Staphylococcus aureus with inducible counter-selection. Plasmid 2006,55(1):58–63.PubMedCrossRef 24.

Science 2001, 294:849–852 PubMed 38 Bolstad BM, Irizarry RA, Ast

Science 2001, 294:849–852.PubMed 38. Bolstad BM, Irizarry RA, Astrand M, Speed TP: A comparison of normalization methods for high density XAV939 oligonucleotide array data based on variance and bias. Bioinformatics 2003, 19:185–193.PubMedCrossRef 39. Kim KY, Kim BJ, Yi GS: Reuse of imputed data in microarray analysis increases

imputation efficiency. BMC Bioinformatics 2004, 5:160.PubMedCrossRef 40. Breitling R, Armengaud P, Amtmann A, learn more Herzyk P: Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments. FEBS Lett 2004, 573:83–92.PubMedCrossRef 41. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA: DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003, 4:3.CrossRef 42. Critical factors for successful Real time PCR Qiagen; 2004. Authors’ contributions ST performed LY2835219 in vitro the experimental work and wrote the

manuscript. RG participated in the statistical analysis of microarray data and in writing the manuscript. HH participated in the statistical analysis of microarray data and in writing the manuscript. TC conceived the study and helped drafting the manuscript. All authors have read and approved the final manuscript.”
“Background The genus Mycobacterium consists of ~148 species [1], of which some are leading human and animal pathogens. Tuberculosis (TB), the most important mycobacterial disease, is caused by genetically related species commonly referred to as “”the Mycobacterium

tuberculosis Complex”" (MTC: Mycobacterium tuberculosis; M. bovis, also the causative agent of bovine TB; M. bovis BCG; M. africanum; M. carnetti and M. microti [2]). M. leprae and M. ulcerans are respectively the causative agents for two other important diseases, Leprosy and Buruli ulcer [3, 4]. Besides the three major diseases, M. avium subsp. Paratuberculosis C-X-C chemokine receptor type 7 (CXCR-7) causes John’s disease (a fatal disease of dairy cattle [5]) and is also suspected to cause Crohn’s disease in humans [5]. In addition, M. avium and other non-tuberculous mycobacteria (NTM) have become important opportunistic pathogens of immunocompromised humans and animals [6, 7]. Mycobacteria have versatile lifestyles and habitats, complexities also mirrored by their physiology. While some can be obligate intracellular pathogens (i.e. the MTC species) [8], others are aquatic inhabitants, which can utilize polycyclic aromatic hydrocarbons (i.e. M. vanbaalenii) [9]. The biology of pathogenic mycobacteria remains an enigma, despite their importance in human and veterinary medicine. Except for the mycolactone of M.

Differences in the number of OTUs among animal diets were evaluat

Differences in the number of OTUs among animal diets were evaluated using an ANOVA (see Tables in manuscript and supplementary information). Here, each dietary treatment was analyzed separately. For multivariate analysis, the 16S OTUs distances among samples first were calculated using the unweighted (bacterial counts as 0 and 1 observations) UniFrac

distance measure ([20], which measures the phylogenetic distances among samples. The weighted (actual abundance) UniFrac distance measure was used because it also considers the relative abundance of each OTU (16S rRNA read) when calculating phylogenetic distances. Principle coordinates analysis (PCoA) was used check details to display these differences in 2 dimensions, thereby facilitating an overall assessment of variability in the entire microbiome among samples. To test for multivariate differences among treatment groups, distance based redundancy analysis (dbRDA) [21] was used. this website In addition, the relative abundances of all genera were evaluated using an ANOVA. Here, relative abundances were transformed (p’ = arcsine (√p)) before analysis, and analyses

were conducted separately for each of the diets. As an initial screening evaluation, uncontrolled p-values were used to screen taxa. Data are illustrated in figures in the manuscript and supplementary information. Rarefaction Epigenetics inhibitor curves and UniFrac distances were calculated using QIIME [22], and all other analyses were conducted in R [23], using the vegan [24] and labdsv [25] packages. Double hierarchal cluster analysis was conducted using NCSS 2007 Orotidine 5′-phosphate decarboxylase software (NCSS, Kaysville, UT) and one-way ANOVA was also conducted using JMP9 software (JMP, SAS, Cary, NC). Acknowledgements The authors recognize

Lana Castleberry for the preparation of community DNA samples for analysis. Electronic supplementary material Additional file 1: Figure S1. Evaluation of Bacteroidetes and Firmicutes relative abundance to the influence of dietary treatments, (A) One-way Analysis of Firmicutes by Treatment, (B) One-way Analysis of Bacteroidetes by Treatment, and (C) Matched pair comparisons testing the response of the ratio of abundances observed between Bacteroidetes and Firmicutes revealing no significant difference between and amongst treatments. (PPT 692 KB) Additional file 2: Figure S2. Evaluation of Phyla showing a response (significant < 0.05, or influenced < 0.1) to dietary treatments (A) Oneway analysis of Synergistetes by treatment, (B) Oneway analysis of WS3 by treatment, (C) Oneway analysis of Actinobacteria by treatment, (D) Oneway analysis of Spirochaetes by treatment. (PPT 110 KB) Additional file 3: Figure S3. Effect of wet DG’s on Beef Cattle Fecal Microbiota.

Conclusions In this study, we were able to clarify the roles of t

Conclusions In this study, we were able to AR-13324 clarify the roles of the seven flagellin subunits in the assembly of the flagellar filament in R. leguminosarum. Taken altogether, our results indicate that FlaA is an essential subunit, but that it is not enough to assemble a fully functional flagellar filament. FlaB and FlaC are major components

of the filament while FlaD, FlaE, FlaH, and FlaG are only minor components. To assemble a fully functional filament, at least three (FlaA, FlaB, and FlaC) and five (FlaA, FlaB, FlaC, FlaE, and FlaG) flagellin subunits should be synthesized by 3841 and VF39SM, respectively. There were selleck chemical no substantial differences in the requirements for individual flagellins BTK inhibitor cost in swimming vs. swarming motility. The flagellins of 3841 and VF39SM are possibly modified by glycosylation. Acknowledgements We gratefully acknowledge the support for this work from Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grants to MFH and SFK. DDT was supported by a Government of Canada graduate scholarship and the Bettina Bahlsen scholarship. We thank Carol Stremick for her help with the protein work as well as Wei-Xiang Dong at the Microscopy and Imaging Facility

of the University of Calgary for his assistance with electron microscopy. We also thank Dr. Christopher K. Yost for his very helpful comments on the manuscript. Electronic supplementary material Additional file 1: Sequences of primers used to PCR amplify flagellin genes. Table showing PCR primer sequences for all PCR work discussed in the paper. (DOC 38 KB) Additional file 2: Details of flagellin gene mutations in R. leguminosarum strains 3841 and VF39SM. Table giving complete description of fragments and cassettes used in construction

of all the mutants described in the paper. (DOC 48 KB) Additional Tau-protein kinase file 3: Immunoblot using an anti-flagellar antibody against flagellar preparations of R. leguminosarum. Figure showing western blot of flagellar preparations of wild type and mutant strains. (PDF 101 KB) Additional file 4: MS/MS spectrum of one tryptic peptide from the data set for VF39SM. Figure showing a Mass Spectrum of a peptide from the tryptic digest of VF39SM flagellar proteins. (PDF 47 KB) References 1. Silverman M: Building bacterial flagella. Q Rev Biol 1980,55(4):395–408.PubMedCrossRef 2. Macnab RM: How bacteria assemble flagella. Annu Rev Microbiol 2003,57(1):77–100.PubMedCrossRef 3. Enomoto M, Sakai A, Tominaga A: Expression of an Escherichia coli flagellin gene, hag48 , in the presence of a Salmonella H1-repressor. Mol Gen Genet 1985,201(1):133–135.PubMedCrossRef 4. Kuwajima G, Asaka J, Fujiwara T, Node K, Kondo E: Nucleotide sequence of the hag gene encoding flagellin of Escherichia coli . J Bacteriol 1986,168(3):1479–1483.PubMed 5.

Appl Phys Lett 2008, 92:082902 CrossRef 39 Dang ZM, Wang L, Yin

Appl Phys Lett 2008, 92:082902.CrossRef 39. Dang ZM, Wang L, Yin Y, Zhang Q, Lei QQ: Giant dielectric permittivities in functionalized CNT/PVDF. Adv Mater 2007, 19:852–857.CrossRef 40. He F, Lau S, Chan HL, Fan J: High dielectric permittivity and low percolation threshold in nanocomposites based on poly(vinylidene fluoride) and exfoliated graphite nanoplates. Adv Mater 2009, 21:710–715.CrossRef 41. Dang ZM, Wu JP, Xu HP, Yao SH, Jiang MJ, Bai JB: Dielectric properties of upright carbon fiber filled poly(vinylidene fluoride) composite with low percolation threshold and week temperature dependence. Appl Phys Lett 2007, 91:072912.CrossRef 42. Barrau S, Demont P, Peigney A, Laurent C, Lacabanne

C: DC and AC conductivity of carbon nanotubes−polyepoxy composites. Macromolecules 2003, 36:5187–5194.CrossRef 43. Jonscher AK: The ‘universal’ dielectric response. Nature 1977, 267:673–679.CrossRef www.selleckchem.com/products/LDE225(NVP-LDE225).html 44. Dyre JC, Schrǿ der TB: Universality of ac conduction in disordered solids. Rev Mod Phys 2000, 72:873–892.CrossRef 45. Ezquerra TA, Connor MT, Roy S, Kulescza M, Fernandes-Nascimento J, Balta-Calleja FJ: Alternating-current electrical properties of graphite, carbon-black and carbon-fiber polymeric

composites. Compos Sci Tech 2001, 61:903–909.CrossRef 46. Connor MT, Roy S, Ezquerra TA J, Balta-Calleja FJ: Broadband ac conductivity of conductor-polymer composites. Phys Rev B 1998, 57:2286–2294.CrossRef 47. Linares A, Canalda selleck chemical JC, Cagiao ME, Garcia-Gutierrez MC, Nogales A, Martin-Gullon I, Vera J, Ezquerra TA: Broad-band electrical conductivity of high density polyethylene nanocomposites with carbon nanoadditives: multiwalled carbon nanotubes and carbon nanofibers. Macromolecules 2008, 41:7090–7097.CrossRef 48. He LX, Tjong SC: Alternating current electrical conductivity

of high density polyethylene–carbon nanofiber composites. Euro Phys J E 2010, 32:249–254.CrossRef 49. He LX, Tjong SC: Electrical conductivity of polyvinylidene fluoride nanocomposites with carbon nanotubes and nanofibers. J Nanosci Nanotech 2011, 11:10668–10672.CrossRef 50. He LX, Tjong SC: Universality of Zener tunneling in carbon/polymer Reverse transcriptase composites. Synth Met 2012, 161:2647–2650.CrossRef 51. Zener C: A theory of the electrical breakdown of solid dielectrics. Proc Roy Soc A 1934, 145:523–539.CrossRef 52. He LX, Tjong SC: Carbon nanotube/epoxy resin composite: correlation between state of nanotube dispersion and Zener tunneling parameters. Synth Met 2012, 162:2277–2281.CrossRef Competing interests The authors declare that they have no competing interests. Authors’ contributions LXH carried out the experiments, selleck kinase inhibitor interpreted the data, and drafted the manuscript. SCT participated in the design of the study, material analysis, and revision of the whole manuscript. Both authors read and approved the final manuscript.